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The purpose of this thesis was to investigate the effects that exercise modalities have on 
neurotrophic and inflammatory blood markers and cognitive outcomes in older adults. A 
systematic review and meta-analysis were completed. The included studies illustrated that 
most of the literature evaluated the effect of aerobic exercise interventions on systemic 
concentrations of the blood marker brain-derived neurotrophic factor (BDNF). The 
review found that aerobic exercise increases BDNF and resistance training increases 
insulin-like growth factor 1 (IGF-1). Interventions with sex-specific cohorts presented 
advantages in males for blood marker and cognitive outcomes compared to females. One 
of three included interventions decreased C-reactive protein (CRP). This thesis 
demonstrated the presence of modality-specific outcomes of exercise on blood markers 











Summary for Lay Audience 
Dementia poses a huge burden to older adults, their caregivers, and society. Patients with 
dementia are faced with increasingly severe and complex impairments to their thinking, 
otherwise known as cognition, which includes processes such as memory, planning, 
organization, attention, language, spatial ability, and ability to orient themselves. 
Additionally, individuals with dementia typically face challenges with mobility, social 
life, and mental health as their condition progresses. 
A possible treatment for dementia is exercise, which has been shown to (at least 
temporarily) improve or prevent worsening of the symptoms of cognitive decline in older 
adults. Past research on exercise as a treatment for individuals with cognitive 
impairments has suggested that exercise triggers a release of specific molecules in the 
blood and, conversely, reduces harmful molecules. More specifically, exercise triggers 
the release of molecules, known as growth factors, that increase blood flow and regulate 
the development, growth, and survival of brain cells. Also, exercise decreases molecules 
in the blood that are related to heart disease and dementia, known as inflammatory 
markers. 
This manuscript aimed to examine the role of key growth factors and inflammatory 
markers in the cognitive outcomes seen after an exercise program. A review of this 
subject was completed and organized to clarify the consensus of all past literature.  
The review found that different exercise types (resistance and aerobic) increased different 
growth factors in the blood. Males showed more positive effects on both blood molecules 
and mental processes after exercise. Additionally, inflammatory markers were reduced 
after exercise in some studies. In conclusion, this manuscript suggested that different 
types of exercise can increase growth factor molecules to improve cognition, and that 
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1 Literature Review 
This thesis aims to evaluate the relationship between longitudinal exercise training and 
cognition, and whether this relationship is modified by neurotrophic growth factors and 
inflammation. Chapter 1 will introduce the topics of cognition, exercise, neurotrophic 
factors, and inflammatory markers. Further, I present the topic of exercise as a non-
pharmacological intervention to reduce age-related cognitive decline. Additionally, I 
describe the impact of growth factors and inflammation on cognition and the role of 
exercise in this relationship. I conclude by providing study rationale, purpose, and 
hypotheses of the ensuing chapters. Chapter 2 presents a review of randomized controlled 
trials investigating the impact of particular exercise modalities on neurotrophic factor and 
inflammatory marker concentrations and cognition. 
1.1 Cognition in Aging 
Cognition is defined as the mental action or process of acquiring knowledge and 
understanding through thought, experience, and the senses (Harada et al., 2013). 
Cognitive decline is a natural result of aging (Harada et al., 2013; Murman, 2015). The 
physiological processes that drive age-related cognitive decline are multifaceted, 
interconnected, and largely undetermined (Harman, 2006; López-Otín et al., 2013; 
Salthouse, 2010). Aging increases the risk of developing cognitive pathologies, which 
can further compound the deleterious effects of cognitive aging (Riedel et al., 2016). 
Researchers have delineated associations between several lifestyle factors and resilience 
to cognitive aging and pathology. Specifically, education, social engagement, physical 
fitness, and life occupation, among others, have been linked to better prognoses of 
cognitive aging (Harada et al., 2013). Also, acute and longitudinal health interventions, 
such as exercise (Northey et al., 2018), cognitive training, or playing a musical 
instrument (Román-Caballero et al., 2018), have exhibited positive results as preventative 




An interesting clinical phenomenon, cognitive reserve, explains the disjunction between 
the expression of cognitive symptoms and the disproportionate severity of cognitive 
pathology present in post-mortem clinical findings (Ince, 2001; Stern, 2009). More 
specifically, cognitive reserve is hypothesized to be an individual’s ability to cope with 
injury to the brain or cognitive decline through the individual differences in neural 
networks and the capacity to reallocate intact networks to surrogate the function of 
damaged networks. Cognitive reserve is postulated to be primarily driven by education, 
occupational exposure, leisure activities, and general cognitive activity throughout the 
lifespan (Stern, 2009; Wilson et al., 2007). 
1.1.1 Domains of Cognition 
There is limited consensus in research and healthcare on the most effective way to divide 
cognition into distinct neurocognitive domains. To attain consistent diagnostic 
categorisation of cognitive impairments, the Diagnostic and Statistical Manual of Mental 
Disorders, fifth edition (DSM-5), gained consensus from leading experts of psychiatric 
research and practice. Based on the consensus established in the DSM-5, cognition is 
divided into six principle domains: Executive Function, Complex Attention, Learning and 
Memory, Perceptual Motor Functioning, Language, and Social Cognition (Sachdev et al., 
2014).  
Hunt et al. (2013) defines executive function as an overarching cognitive process, 
mediated by attention, that coordinates and integrates multiple subordinate cognitive 
skills to enable goal-directed behaviour.  Executive function is categorized into several 
sub-domains, including planning, decision making, working memory, responding to 
feedback, inhibition, and flexibility (Sachdev et al., 2014). Additionally, Miyake et al. 
(2000) explored the existence of three frequently postulated executive sub-components: 
inhibition, shifting, and updating. These three sub-components can respectively be 
defined as the ability to suppress dominant, automatic, or prepotent responses when they 
are inappropriate, as the ability to shift attention between different sub-tasks or different 
elements of the same tasks, and finally, as the ability to evaluate incoming information 
and revise the existing contents of working memory by deleting what is no longer 




Attention is defined as the behavioral and cognitive process of selectively concentrating 
on a discrete aspect of information, whether deemed subjective or objective, while 
ignoring other perceivable information (Anderson, 2004). Complex attention is 
categorized into several sub-domains including sustained attention, divided attention, 
selective attention, and processing speed. (Sachdev et al., 2014). 
The Encyclopedia of Psychology defines learning as the acquisition of a skill or 
knowledge, and memory as the expression of previously learned information (Kazdin et 
al., 2000). Learning and memory are categorized into the sub-domains free recall, cued 
recall, recognition memory, semantic and autobiographical, long-term memory, and 
implicit memory (Sachdev et al., 2014). 
Perceptual-motor function is the accurate integration of sensory information for the 
development of motor programming and perceptual orientation (Finney, 2015). This 
cognitive domain is categorized into visual perception, vasoconstriction reasoning, and 
perceptual-motor coordination (Sachdev et al., 2014). 
Language is defined as the development, acquisition, and maintenance, and use of 
complex systems of communication (Ramlan, 2018). Language is differentiated into sub-
domains that include object naming, word finding, fluency, grammar and syntax, and 
receptive language (Sachdev et al., 2014) 
1.1.2 Epidemiology of Cognitive Dysfunction 
The intermediate state between normal aging and dementia is known as mild 
neurocognitive disorder (Sachdev et al., 2014), or more commonly mild cognitive 
impairment (MCI). The prevalence of MCI is 10-20% in older adults over 65 years of age 
(Langa & Levine, 2014). Those diagnosed with MCI have a 20-40% (10-15% per year) 
risk of progression into dementia (Roberts & Knopman, 2013). The most significant risk 
factors of cognitive decline and cognitive pathology are age, sex, genetics, and the 





The prevalence of cognitive decline is predicted to rise substantially in the approaching 
decades. Researchers predict that by 2050 the population of those 65 years and older will 
double, while the population of those 85 years and older will triple. Further, it is 
estimated that 35.6 million people live with dementia worldwide, and this number will 
double every 20 years (Mavrodaris et al., 2013). Consequently, interest in research has 
risen dramatically for the treatment or prevention or cognitive decline (Cummings et al., 
2018; Morrison-Bogorad et al., 2007). 
Research suggests that females are more susceptible to cognitive pathologies compared to 
males (Barha & Liu-Ambrose, 2018); the incidence of cognitive decline is twice as likely 
in female older adults (Lin & Doraiswamy, 2015) and females exhibit more rapid brain 
atrophy than males after onset of cognitive pathology (Hua et al., 2010).  Also, the 
association between peripheral inflammatory markers and cognitive decline is more 
evident in females than males (Trollor et al., 2012). Further, both natural and surgical 
menopause are associated with an increased risk of Alzheimer’s disease biomarkers and 
cognitive decline (Hara et al., 2015; Mosconi et al., 2017; Rocca et al., 2007; Scheyer et 
al., 2018). 
1.1.3 Measuring Cognitive Function 
Various cognitive assessments have been validated in measuring cognitive performance 
in different age groups. These assessments can be combined to measure cognitive 
performance in general, or particular domains of interest. Cognitive assessments 
commonly used for older adults include: Trail Making Test (Reitan and Wolfson 1985), 
Digit Span (Wechsler, 1981), Letter Number Sequence (Wechsler, 1981), and Language 
or Category Fluency (Strauss et al., 2006), and Rey Auditory Verbal Learning Test 
(Rosenberg et al., 1984). Various cognitive assessment batteries that include multiple 
assessments have been developed for comprehensive assessments of older adults. Most 
notable are the Montreal Cognitive Assessment (MoCA), the Mini Mental State 
Examination (MMSE), both of which are short assessments typically used as screening 




Disease Assessment Scale (ADAS-Cog) that has been used in clinical trials (Kueper et 
al., 2018; Montero Odasso et al., 2018; Rosen et al., 1984).  
The ADAS-Cog is a valid and reliable battery of cognitive assessments to determine 
global cognition related to cognitive impairment in older adults (Sheehan, 2012). The 
ADAS-Cog Plus, a revised version of the ADAS-Cog, incorporates additional measures 
of executive function and functionality. This scale consists of 10 cognitive tests, with 
scores ranging from 0 to 90; higher scores represent poorer cognitive performance 
(Skinner et al., 2012). Compared to previous versions, the ADAS-Cog Plus is more 
responsive to disease progression and treatment effects in studies of cohorts with MCI 
(Kueper et al., 2018). The ADAS-Cog has been a significant outcome measure in 
numerous trials with MCI and AD (Chupel et al., 2017; Fiatarone Singh et al., 2014; 
Öhman et al., 2014; Suzuki et al., 2013; Toots et al., 2017).  
1.2 Physical Exercise 
Caspersen, Powell, and Christenson (1985) define exercise as “Physical activity that is 
planned, structured, repetitive, and purposive in the sense that improvement or 
maintenance of one or more components of physical fitness is an objective”. The 
objective of physical exercise is physical fitness, which can be divided into two 
components, with specific sub-categories: (1) health-related objectives, including 
cardiorespiratory capacity, muscular endurance, muscular strength, body composition, 
and flexibility; and (2) skill-related, including agility, balance, coordination, speed, 
power, and reaction time. If a physical activity does not intentionally fulfil any of these 
aspects of physical fitness, then it is not considered exercise.  
In trials with older adults, the primary consideration of an exercise interventions is 
usually health-related outcomes of strength, fall reduction, mobility, cardiovascular 
fitness, physical function, depression, and cognitive outcomes (Cadore et al., 2013; Chen 
et al., 2020; Shekelle et al., 2003). Common exercise modalities for older adults include 




1.2.1 Aerobic Exercise 
Aerobic exercise involves the use of large muscle groups in dynamic activities that result 
in sustained increases in heart rate and energy expenditure (Howley, 2001). Aerobic 
exercise is primarily related to the health-related outcomes of cardiorespiratory capacity, 
muscle endurance, and body composition due to the moderate-energy, long-duration 
nature of the exercise (Plowman & Smith, 2008). Aerobic exercise is commonly 
implemented on ergometer machines (treadmills, stationary bikes, ellipticals, rowing 
machines, etc.), walking, running, or biking, depending on the fitness level and capability 
of the subjects. 
1.2.2 Resistance Exercise  
Resistance exercise is the repeated lifting of weight to overload muscles at an intensity 
only sustainable for a short duration. The parameters of resistance training include the 
number of times the resistance is moved in a single set of exercise, the number of sets 
done, and the rest interval between sets (Howley, 2001). Resistance exercise is primarily 
related to the health-related outcomes of muscular strength, muscular endurance, and 
body composition. Also, secondary skill-related enhancements in balance, agility, speed, 
and power can be attained through resistance exercise (Plowman & Smith, 2008). 
Common forms of resistance training include the use of free-weights, resistance machines 
(e.g., leg press, chest press, leg curl, etc.), resistance bands, and body weight exercises 
(e.g., pull-ups, push-ups, bodyweight squats, etc.).  
1.2.3 Balance, Toning, and Stretching Exercise 
Balance, toning, and stretching exercises usually exercises that are designed to improve 
balance, muscle tone, and lengthen muscles, respectively. Balance exercises typically 
challenge balance systems by limiting senses related to balance, such as sight, 
proprioception, foot pressure, and vestibular function, and limiting the base of support 
with or without perturbing the centre of gravity of the participant. Common balance 




tandem stance, all usually administered over a set duration (Penzer et al., 2015; Shimada 
et al., 2003). Toning exercises are exercises that utilize large muscle groups but do not 
significantly overload the muscles or cause a significant cardiovascular response. Finally, 
stretching exercises are movements intended to lengthen muscles and improve range of 
motion for targeted joints (Page, 2012). 
Balance, toning, and stretching exercises are commonly used in-combination as active 
controls for exercise interventions in cognitive trials. This is due to a speculated lack of 
amelioration on cognitive dysfunction (Kelly et al., 2014; Uffelen et al., 2008). However, 
some forms of this modality are studied due to their proposed mental and emotional 
enhancements, such as yoga, tai chi, and Qigong (Abbott & Lavretsky, 2013; Farhang et 
al., 2019; Mooventhan & Nivethitha, 2017).  
1.3 Blood Biomarkers Related to Cognition 
Particular blood biomarkers have been identified as having important roles in the 
regulation of cognitive functioning. Specifically, neurotrophic growth factors (Campos, 
Rocha, Lattari, Paes, & Nardi 2016; Raab et al., 2004), and inflammatory cytokines (Gu 
et al., 2017; Teunissen et al., 2003) have been found to exert trophic and atrophic effects 
on the neural and vascular structures in the brain, respectively (Cotman et al., 2007; 
Nascimento et al., 2014).  
1.3.1 Neurotrophic Factors 
Studies have identified particular neurotrophic factors thought to be associated with 
positive cognitive outcomes after exercise (Ding et al., 2006; Hillman et al., 2008). The 
primary neurotrophic growth factors implicated in this relationship are brain-derived 
neurotrophic factor (BDNF), insulin-like growth factor 1 (IGF-1), and vascular 
endothelial growth factor (VEGF) (Cotman et al., 2007).  These molecules play 
convergent roles in the neuroplastic processes, including gliogenesis, neurogenesis, 




The protein BDNF is expressed in the central nervous system, gut, and other tissues, and 
is a member of the neurotrophin family (Bathina & Das, 2015). Functionally, BDNF 
enhances the growth and differentiation of cells in the brain and is essential to the 
development of the mammalian brain (Binder & Scharfman, 2004). Specifically, the 
expression of BDNF contributes to neurogenesis (Benraiss et al., 2001; Pencea et al., 
2001), gliogenesis (Cheng et al., 2006), synaptogenesis (Aguado et al., 2003; Alsina et 
al., 2001; Binder & Scharfman, 2004) and angiogenesis (Kermani & Hempstead, 2007). 
BDNF is largely expressed in the hippocampus, which is the brain centre for emotion, 
memory, and learning (Erickson et al., 2011; Lu et al., 2014). Low blood concentrations 
of BDNF have been associated with neurodegenerative diseases, such as dementia 
(Weinstein et al., 2014), Alzheimer’s disease (Laske et al., 2006; Ng et al., 2019), 
Huntington’s disease (Zuccato & Cattaneo, 2009), and the early stages of Parkinson’s 
disease (Huang et al., 2018).  
The signal protein VEGF is released from the endothelial cells in blood vessels, 
macrophages, and glial cells in response to tissue hypoxia (Roskoski, 2007; Tang et al., 
2010) and the presence of blood lactate (Morland et al., 2017) and functions to stimulate 
angiogenesis and vasculogenesis ubiquitously in the body (Hoeben et al., 2004). VEGF 
transcription in the brain is thought to elicit neurotropic and neuroprotective functions 
(Jin et al., 2002; Sun et al., 2003; Tang et al., 2010). The specific functions of VEGF are 
increasing neuronal survival, decreasing apoptotic proteins and signals, stimulating the 
release of proteins that improve neuronal health (Sanchez et al., 2010), and increasing 
general plasticity of mature neurons (Licht et al., 2011). Animal studies have discovered 
a marked decline in VEGF concentrations in the hippocampus occurring until middle-age 
that may contribute to age-related cognitive decline (Shetty et al., 2005).  
The vascular and neuroprotective functions of VEGF are especially pertinent in the 
context of vascular dementia (Ding et al., 2004; Sun et al., 2003). After a cerebral 
vascular event, such as a stroke, VEGF is released to the affected area to promote 
angiogenic and vasculogenic activity (Krupinski et al., 1994). Patients who have 




VEGF have significantly better prognoses than those with lower systemic concentrations 
(Lee et al., 2010). Interestingly, patients afflicted by an acute stroke who had previous 
transient ischemic attacks (TIA) have better prognoses than those without, thought to be 
mediated by a higher concentration of VEGF following the damage associated with TIA 
(Kwon et al., 2015). Thus, the negative impacts of stroke may be mitigated by high 
concentrations of VEGF in the cerebral vasculature due to its role in angiogenesis and 
vasculogenesis. 
The protein hormone IGF-1 is released by cells of the liver, lungs, kidneys, skeletal 
muscle, heart, and white adipose tissue in the presence of circulating growth hormone 
(GH) (Lowe et al., 1988). The primary function of IGF-1 is to stimulate anabolism 
throughout the mammalian body (Le Roith et al., 2001), including neurogenesis (Llorens-
Martín et al., 2009), gliogenesis (Carson et al., 1993), synaptogenesis (Trejo et al., 2007), 
and angiogenesis (Lopez-Lopez et al., 2004) and is essential for human brain 
development (Maggio et al., 2012). As humans age, systemic concentrations of GH 
typically decrease, resulting in a downregulation of IGF-1 (Corpas et al., 1993). Further, 
research has shown that lower concentrations of  IGF-1 are associated with cognitive 
aging (Corpas et al., 1993; Sonntag et al., 2005); lower cognitive functioning in older 
adults, with, and without, MCI; and an increased risk of Alzheimer’s disease and vascular 
dementia (Watanabe et al., 2005) .  
1.3.2 Inflammation and Inflammatory Cytokines 
Inflammation is the body’s immune response to harmful stimuli and functions to 
eliminate necrotic cells and promote healing. Although inflammation is beneficial and 
necessary for normal bodily functioning (Gronke et al., 2019), chronic low-grade 
inflammation is particularly detrimental to heart and brain health (Nicklas & Brinkley, 
2009). The incidence of inflammatory pathogenesis is dependent on the level of 
inflammation in an individual’s body and their threshold of disease, adjusted by genetic 




The term inflammaging refers to a chronic low-grade inflammatory state resulting from 
the upregulation of the inflammatory response compelled by multiple factors in old age. 
These factors are speculated to be driven by the culmination of antigenic stressors over 
the human lifespan and dysregulated inflammatory processes (Rea et al., 2018). 
Inflammaging likely represents a mechanism underlying the age-related functional 
decline across a variety of pathological states (Nicklas & Brinkley, 2009). Research has 
also demonstrated an association between chronic low-grade inflammation and attenuated 
hippocampal neurogenesis (Chesnokova et al., 2016; Kohman & Rhodes, 2013), 
increased risk of stroke with poor functional outcomes and mortality (Ballantyne et al., 
2005; Elkind et al., 2006), cognitive impairment (Wichmann et al., 2014), and 
Alzheimer’s disease (Heneka et al., 2015; Krabbe et al., 2004). Multiple studies 
measuring the effect of inflammation on cognition have employed the inflammatory 
cytokines interleukin 6 (IL-6) and C-reactive protein (CRP) as valid markers of systemic 
inflammation and inflammaging (Capuron et al., 2011; Gabay & Kushner, 1999; Ohzato 
et al., 1992; Tegeler et al., 2016; Yaffe et al., 2003). 
The inflammatory protein IL-6 is secreted by macrophages and T-cells in the bloodstream 
and has both pro- and anti-inflammatory functions (Pedersen & Febbraio, 2008; Scheller 
et al., 2011). Specifically, IL-6 is released as a pro-inflammatory cytokine in response to 
injury, cell damage, and cell death. However, in response to muscle contraction, IL-6 is 
transiently released as an anti-inflammatory myokine (Pedersen & Febbraio, 2008). 
Though IL-6 has anti-inflammatory pathways, elevated concentrations of IL-6 in the 
systemic circulation have been associated with lower cognitive performance (Bradburn et 
al., 2018; Trollor et al., 2012) and brain volume (Gu et al., 2017).  This relationship is 
thought to be mediated through the detrimental effects of chronic low-grade 
inflammation as well as inflated cytokine responses to ischemia that exacerbate cell 
damage in the brain (Michaud et al., 2013).  
The protein CRP is an acute-phase inflammatory protein that is released from the liver in 
response to circulating IL-6 (Pepys & Hirschfield, 2003). The measurement of CRP is 
used as a standard clinical procedure that indicates the systemic level of inflammation in 




infections, or inflammatory disorders (Bray et al., 2016; Pepys & Hirschfield, 2003). 
High concentrations of CRP are associated with cognitive decline, dementia, and an 
increased risk of stroke (Kuo et al., 2005; Misiak et al., 2018).  
1.4 Exercise as a Treatment for Cognitive Decline in 
Aging  
The use of exercise as a non-pharmaceutical intervention to delay or prevent the 
trajectory into dementia is a rapidly growing field of interest. Longitudinal exercise 
programs have shown promise in eliciting significant improvements in cognitive 
performance with modality-dependent domain-specific effects (Barha, Davis, Falck, 
Nagamatsu, & Liu-Ambrose, 2017). A meta-analysis, which included individuals over 50 
years of age, found that exercise elicited a positive small to moderate effect on improving 
cognitive performance. This effect was consistent regardless of cognitive status, cognitive 
domains measured, and the exercise modality utilized (Northey et al., 2018). Other meta-
analyses have investigated this relationship in participants with MCI with variable results. 
In particular, studies primarily found small to moderate improvements in global 
cognition, memory, and executive function (Biazus-Sehn et al., 2020; Zheng et al., 2016). 
Conversely, Gates, Singh, Sachdev, & Valenzuela (2013) completed a meta-analysis on 
the effect of exercise on cognition in individuals with MCI, but did not find significant 
outcomes. Interestingly, Biazus-Sehn et al. (2020) found that trials utilizing more 
cognitively engaging forms of exercise (i.e., dance, Tai Chi, Baduanjin) in older adults 
with MCI had better cognitive outcomes than simple physical exercise regimens. These 
findings are consistent with the results from a meta-analysis investigating the effect of 
aerobic dance interventions on cognition. The study found that the dance interventions 
had a moderate effect on memory, executive function, and global cognition (Zhu et al., 
2020). These results may be indicative of a synergistic training effect related to the 




1.4.1 Physical Exercise and Blood Markers Associated 
with Cognition  
Exercise-induced physiological cascades are known to regulate cognition by exerting 
trophic effects on neural and vascular structures in the brain (Campos, Rocha, Lattari, 
Paes, & Nardi 2016; Raab et al., 2004) and preventing brain atrophy associated with 
inflammation (Gu et al., 2017; Teunissen et al., 2003). Consequently, the relationship 
between physical exercise and cognition is thought to be mediated by the change in 
growth factors and inflammatory markers (Cotman et al., 2007; Nascimento et al., 2014) 
1.4.1.1 Neurotrophic Growth Factors and Cognition in 
Response to Exercise  
Neurotrophic growth factors mediate the effects of exercise on cognitive performance. 
Comprehensive reviews have established that BDNF, VEGF, and IGF-1 are the principal 
mediating neurotrophic growth factors in the exercise-cognition relationship (Cotman et 
al., 2007; El-Sayes et al., 2019). Figure 1.1 describes the model of neurotrophic growth 
factor and cognitive outcomes induced by physical exercise. Animal trials have 
established divergent exercise modality-dependent relationships for neurotrophic growth 
factors and cognitive outcomes. In particular, it is thought that aerobic exercise increases 
BDNF concentrations and resistance training upregulates IGF-1 activity, both mediating 
improvements of cognitive outcomes (Cassilhas et al., 2012). A meta-analysis by Dinoff 
et al. (2016) investigating the effect of exercise on concentrations of BDNF supported 
this theory that aerobic and not resistance exercise increased resting systemic BDNF 
concentrations in humans. Other RCTs have supported these speculated modality-specific 
pathways to improve cognitive outcomes (Cassilhas et al., 2007; Jiang et al., 2020; Tsai 
et al., 2019), as well as possible synergistic effects of multimodal exercise interventions 
(Annibalini et al., 2017). The effect of exercise on VEGF in cognitive trials in humans 
has been studied considerably less than BDNF and IGF-1. In fact, most of the literature 
on this relationship has been established through animal trials (Cao et al., 2004; Y.-H. 
Ding et al., 2004; Fabel et al., 2003; Lopez-Lopez et al., 2004; Prior et al., 2004) and 




VEGF in older adults describes that four of ten studies found significant increases in 
VEGF concentrations post-intervention. The review was limited by the small number of 
included studies, and a wide variety of intervention parameters (exercise duration, 
frequency, intensity, type) and sample characteristics (Vital et al., 2014). Further research 
evaluating the effect of exercise on VEGF to affect cognition is required to delineate this 
relationship in humans.  
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1.4.2.2 Inflammation and Cognition in Response to Exercise  
Longitudinal exercise attenuates inflammation and improves cognition (Gleeson et al., 
2011). Figure 1.2 describes the possible mechanisms in which inflammatory cytokines 
mediate cognitive changes after longitudinal exercise. The mechanism driving the anti-
inflammatory response of exercise is largely unknown, but the overall relationship has 
been well established. Specifically, recent meta-analyses found that exercise was 
associated with significant decreases in IL-6 concentrations in older adults with cognitive 
impairments (Stigger et al., 2019) and resistance training was associated with decreases 
in CRP and IL-6 concentrations for older adults (Sardeli et al., 2018). Further, multiple 
randomized controlled trials (RCTs) have found evidence that longitudinal exercise 
reduces inflammation. In particular, concentrations of CRP and IL-6 were reduced by 
dance training (Borges et al., 2019), combined aerobic and resistance training (Annibalini 
et al., 2017; Balducci et al., 2010), and high-intensity aerobic training, but not low-
intensity aerobic training (Balducci et al., 2010). Other trials found that aerobic and 
resistance training interventions both decreased CRP, but not IL-6 concentrations 
(Donges et al., 2010) and did not influence CRP or IL-6 concentrations (Libardi et al., 
2012). Cognition, however, was not measured in the aforementioned reviews or RCTs. 
Exercise interventions that included the measurement of both cognition and inflammation 
found unanimously that CRP decreased while cognitive performance improved. These 
RCTs utilized resistance training (Chupel et al., 2017) and aerobic training (Alghadir et 
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1.5 Overview of Thesis  
1.5.1 Study Rationale 
The previous sections summarize the literature surrounding cognition and exercise and 
explores the how neurotrophic growth factors and inflammation interact with this 
relationship. Evidence suggests that exercise may have advantages in ameliorating 
cognitive impairment. However, the varying effects of exercise modalities and 
subsequent biomarkers involved in this relationship have not been sufficiently explored 
in research. Exercise modalities may drive divergent changes at the molecular level (i.e., 
neurotrophic and inflammatory markers), which may describe the changes at the 
cognitive level in older adults. 
1.5.2 Purpose 
The purpose of this thesis was to systematically review the effects of exercise modalities 
on neurotrophic factors, inflammation, and cognition, among older adults and to perform 
a meta-analysis of the included studies, if feasible. 
1.5.3  Hypotheses  
It was hypothesized that:  
1) The increase in neurotrophic factor and decrease in inflammatory marker 
concentrations, as a result of exercise, will be associated with cognitive outcomes.  
1.1) Exercise will increase growth factor concentrations, which will be associated with an 
improvement in cognition. 
1.2) Exercise will decrease inflammatory markers, which will be associated with an 
improvement in cognition.  
2) Higher baseline concentrations of growth factors and lower baseline concentrations of 
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Physical exercise has been shown to prevent age-related cognitive decline, and has even 
led to significant cognition improvement in older adults (Ahlskog et al., 2011; Bherer and 
Erickson, 2013; Groot et al., 2016; Hess et al., 2014; Öhman et al., 2014). The underlying 
mechanisms for these improvements are unknown but emerging evidence shows that 
physical exercise increases neurotrophic factors (which consist of a family of molecules 
that support the growth and survival of neurons). Conversely, concentrations of 
inflammatory cytokines (which impair signal transduction of neurons) are significantly 




role in promoting cognitive improvement (Cotman et al., 2007). It is hypothesised that 
these changes stimulate a physiological cascade that promotes angiogenesis, gliogenesis, 
neurogenesis, and synaptogenesis, while reducing systemic inflammation (Cotman et al., 
2007; El-Sayes et al., 2019; Nicklas and Brinkley, 2009). 
Several studies have identified neurotrophic and inflammatory markers associated with 
positive cognitive outcomes after exercise (Ding et al., 2006; Hillman et al., 2008). The 
primary neurotrophic factors implicated in this relationship are brain-derived 
neurotrophic factor (BDNF), insulin-like growth factor 1 (IGF-1), and vascular 
endothelial growth factor (VEGF) (Ahlskog et al., 2011; Cotman et al., 2007; Voss et al., 
2013). Alternatively, inflammatory cytokines interleukin 6 (IL-6) and C-reactive protein 
(CRP) are valid markers of systemic inflammation that impede neuronal signalling 
(Capuron et al., 2011; Gabay and Kushner, 1999; Ohzato et al., 1992; Tegeler et al., 
2016; Yaffe et al., 2003). 
Mechanistically, the aforementioned inflammatory cytokines and neurotrophic factors 
influence cognitive performance via a cascade of neurological processes. For example, 
BDNF regulates synaptic transmission in neural regions that are integrally related to 
memory such as the hippocampus (Lu et al., 2014). Across a range of neural networks, 
BDNF is also critically related to neuroprotection, neuromodulation, and neurogenesis 
(i.e., gliogenesis and synaptic plasticity; Kowiański et al., 2018). Increases in 
inflammatory cytokines, on the other hand, are associated with cognitive decline via 
neuroinflammatory processes. CRP, for example, is strongly associated with the 
progression of cognitive decline and the pathogenesis of the onset of dementia (Roberts 
et al., 2009). Thus, efforts to enhance neurotrophic factors and reduce inflammatory 
cytokines are essential in potentially increasing cognitive performance in individuals at 
risk for developing dementia. 
A recent systematic review and meta-analysis investigated the changes in neurotrophic, 
inflammatory, and oxidative biomarkers after exercise interventions in older adults with 
mild cognitive impairment and dementia (Stigger et al., 2019). The reviewers concluded 




expression, and a decrease in systemic concentrations of IL-6. However, this review was 
limited by the lack of studies with cognitive performance measures, the limited number 
of trials that met the inclusion criteria (n = 8), and the exclusion of cognitively healthy 
participants. 
To our knowledge, no prior systematic review has examined the distinct effects of the 
main physical exercise modalities (aerobic, resistance, and multimodal) on serum 
biomarkers in cognitive trials that included both cognitively healthy and cognitively 
impaired older adults. The inclusion of studies targeting cognitive healthy and impaired 
older adults may improve our understanding of how cognitive status affects blood marker 
concentrations as well as cognitive outcomes after physical exercise. Further, this review 
will summarize our existing knowledge of the physiological mechanisms driving the 
neurotrophic, inflammatory, and cognitive outcomes after exercise. Therefore, the 
purpose of this systematic review and meta-analysis was to investigate the effects of 
physical exercise modalities on inflammatory and neurotrophic biomarker concentrations 
in clinical trials that examined the effects of exercise on cognition in older adults. 
2.1  Methods 
2.1.1  Study Design & Search Strategy 
This systematic review and meta-analysis was registered with PROSPERO – 
CRD42019110522 (Appendix 1), an international database for prospectively registered 
systematic reviews that are examining health-related outcomes. 
We utilized the preferred reporting items for systematic reviews and meta-analyses 
(PRISMA) statement (Moher et al., 2009). A literature search, without date or language 
restrictions, was conducted via PubMed, SCOPUS, and EMBASE for literature published 
prior to January of 2019. The search applied appropriate medical subject headings 
(MeSH) in PubMed and SCOPUS, and subject headings in EMBASE (Tables 2.1, 2.2 ). 
This systematic review was registered with PROSPERO – CRD42019110522 (Appendix 
2), an international database for prospectively registered systematic reviews that are 




systematic reviews and meta-analyses (PRISMA) statement (Moher et al., 2009). A 
literature search, without date or language restrictions, was conducted via PubMed, 
SCOPUS, and EMBASE for literature published prior to January of 2019. The search 
applied appropriate medical subject headings (MeSH) in PubMed and SCOPUS, and 
subject headings in EMBASE (Tables 2.1, 2.2). 
 
Table 2.1 Search terms. 
Note: BDNF = Brian Derived Neurotrophic Factor; IGF-1 = insulin-like growth factor 1; VEGF = 




Main Concepts PubMed MeSH Term 
EMBASE Subject 
Heading 
SCOPUS MeSH Term 
Exercise 
Exercise OR Physical 
Exercise OR Physical 
Activity 
Exercise OR Physical 
Activity OR Physical 
Exercise 
Exercise OR Physical 
Activity OR Activities 
Cognition 
Cognition OR Cognitive 
Dysfunction OR Cognitive 
Impairment OR Executive 
Function 
Cognition OR Cognitive 
Dysfunction OR Mild 
Cognitive Impairment OR 
Executive Function 
Cognition OR Executive 
Function 
Elderly Aged OR Elderly Aged OR Elderly Aged OR Elderly 
Blood Biomarkers Blood Biomarkers Blood Biomarkers Blood Biomarkers 
Brain Derived 
Neurotrophic Factor 
Brian Derived Neurotrophic 
Factor OR BDNF 
Brian Derived 
Neurotrophic Factor OR 
BDNF 
Brain-derived 




Insulin-like Growth Factor 1 
OR IGF-1 
Insulin-like Growth Factor 
1 OR IGF-1 
 
Insulin-like Growth 




Growth Factor OR VEGF 
Vascular Endothelial 
Growth Factor OR VEGF 
Vascular Endothelial 
Growth Factor OR VEGF 
Interleukin 6 Interleukin 6 OR IL-6 Interleukin 6 OR IL-6 Interleukin-6 OR IL-6 
C-Reactive Protein C-Reactive Protein OR CRP 
C-Reactive Protein OR 
CRP 





Table 2.2 Search strategy for PubMed, EMBASE, and SCOPUS.     
Using PubMed Database 
1. Exercise/ OR Physical Exercise/ OR Physical Activity/ 
2. Cognition/ OR Cognitive Dysfunction/ OR Cognitive Impairment/ Or Executive Function/ 
3. Aged/ OR Elderly/ 
4. Blood Biomarkers/ 
5. Brian Derived Neurotrophic Factor/ OR BDNF/ 
6. Insulin-like Growth Factor 1/ OR IGF-1/ 
7. Vascular Endothelial Growth Factor/ OR VEGF/ 
8. Interleukin 6/ OR IL-6/ 
9. C-Reactive Protein/ OR CRP/ 
10. Strategy 4 AND 5 OR 6 OR 7 OR 8 OR 9 
11. Strategy 1 AND 2 AND 3 AND 10 
Using EMBASE Database 
1. Exercise/ 
2. Physical Activity/ 
3. Physical Exercise/ 
4. Strategy 1 OR 2 OR 3 
5. Cognition/ 
6. Executive Function/  
7. Mild Cognitive Impairment/ 
8. Strategy 5 OR 6 OR 7 
9. Aged/ 
10. Elderly/ 
11. Strategy 10 OR 11 
12. Blood Biomarkers/ 
13. Brian Derived Neurotrophic Factor/ 
14. BDNF/ 
15. Strategy 14 OR 15 
16. Insulin-like Growth Factor 1/ 
17. IGF-1/ 
18. Strategy 17 OR 18 
19. Vascular Endothelial Growth Factor/ 
20. VEGF/ 
21. Strategy 20 OR 21 
22. Interleukin 6/ 
23. IL-6/ 
24. Strategy 23 OR 24 
25. C-Reactive Protein/  
26. CRP/ 
27. Strategy 26 OR 27 
28. Strategy 4 AND 9 AND 12 AND 13 AND 16 AND 19 AND 22 AND 25 AND 28 
Using SCOPUS Database 
1. Exercise/ 
2. Physical Activity/ 
3. Activities/ 
4. Strategy 1 AND 2 AND 3 
5. Cognition/  
6. Cognitive Dysfunction/  
7. Cognitive Impairment/  
8. Executive Function/ 
9. Strategy 5 OR 6 OR 7 OR 8 





12. Strategy 10 OR 11 
13. Blood Biomarkers/ 
14. Brian Derived Neurotrophic Factor/  
15. BDNF/ 
16. Strategy 14 OR 15 
17. Insulin-like Growth Factor 1/  
18. IGF-1/ 
19. Strategy 17 OR 18 
20. Vascular Endothelial Growth Factor/ 
21. VEGF/ 
22. Strategy 20 OR 21 
23. Interleukin 6/  
24. IL-6/ 
25. Strategy 23 OR 24 
26. C-Reactive Protein/  
27. CRP/ 
28. Strategy 26 OR 27 
29. Strategy 4 AND 9 AND 12 AND 13 AND 16 AND 19 AND 22 AND 25 AND 28 
 
2.1.2  Screening 
After completing the initial search, all duplicates were removed. To be included, articles 
must have met the following criteria: 1) Published as a randomized controlled trial (RCT) 
or quasi-randomized controlled trials (QRCT); 2) measured at least one of BDNF, VEGF, 
IGF-1, CRP, and IL-6, both before and after a longitudinal (>1 session) exercise 
intervention; 3) measured cognitive performance both before and after a longitudinal (>1 
session) exercise intervention; 4) included a sample with a mean age of 60+ years, who 
were not taking cognitive enhancers, neuroleptics, or anticholinergics, and with an 
absence of neurological conditions with a residual motor deficit (Parkinson’s disease, 
major stroke, multiple sclerosis), or depression, schizophrenia, severe anxiety, and drug 
abuse. 
The titles and abstracts of the remaining articles were independently screened by two 
authors (JT and NB). The remaining articles then underwent a full-text review. 
Disagreements of the selected articles based on the criteria were settled by consensus of 
the two members, and if consensus could not be reached, the third reviewer (MMO) was 
consulted to make a decision. The bibliographies of all included articles were hand-




Caspersen et al. (1985) defined exercise as “Physical activity that is planned, structured, 
repetitive, and purposive in the sense that improvement or maintenance of one or more 
components of physical fitness is an objective”. Physical fitness is composed of two 
categories inclusive of specific sub-categories: 1) Health-related: Cardiorespiratory 
capacity, muscular endurance, muscular strength, body composition and flexibility; 2) 
Skill-related: Agility, balance, coordination, speed, power, and reaction time. 
2.1.3  Bias Assessment 
The Cochrane Collaboration Tool (CCT) was used to appraise the risk of bias (Higgins et 
al., 2011) because of its recommendation for use in systematic reviews examining RCTs 
(Zeng et al., 2015). Additionally, the CCT has been used in other similar systematic 
reviews examining exercise, cognition (Hess et al., 2014), and blood biomarkers (Stigger 
et al., 2019). The CCT is a bias detection tool based on 7 domains, each of which can be 
ranked as low, high, unclear or not applicable (Fig. 2). Reviewers agreed to be 
conservative when deciding between two bias ratings by tending toward higher ratings of 
bias. 
2.1.4  Outcome Measures 
The primary outcome measure was the change in concentrations of the specified blood 
biomarkers (BDNF, VEGF, IGF-1, IL-6, CRP) from pre- to post-exercise intervention. 
The secondary outcome was the change in cognitive performance scores on 
neuropsychological assessments. Cognitive performance was split into five domains, 
when available, as defined by the Diagnostic and Statistical Manual of Mental Disorders, 
5th edition (DSM-5), criteria (Sachdev et al., 2014) The domains included: Learning and 
memory (LM), Complex Attention (CA), Executive Function (EF), Language, 
Perceptual-Motor Function (P-MF), and Global Cognition (GC). 
2.1.5  Data Extraction 
The following information was extracted from the articles selected for final analysis: 




(cohort, sample size, age), intervention details (exercise type, duration/frequency/time), 
primary outcome (significant change in specified blood biomarker concentrations), and 
secondary outcomes (cognitive changes in particular domains or global cognition, as 
applicable) (Table 2.3, Table 2.4, Table 2.5). 
Due to the lack of raw data (pre- and post-intervention means, or mean change values) in 
almost half of the included trials (47 %), measures for the change in both blood 
biomarker concentrations and cognitive performance outcomes were simplified to either a 
“↑” representing a statistically significant increase and improvement, respectively, or a 
“↓” representing a statistically significant decrease and decline, respectively. For the data 
to be determined as statistically significant, results must be significant relative to both 
within-group time analyses and between-group comparisons to the control group. 
In addition to the qualitative analyses, we planned on examining the strength of the 
evidence quantitatively by conducting a meta-analysis using Review Manager 5.3©. 
Additional inclusion criteria for the MA were reporting mean and standard deviation 
values at follow-up post-intervention in both control and experimental conditions. 
Included studies were also required to report a sample size. 
We set the minimum number of independent studies needed for our meta-analysis at 
three. The data extracted were continuous and the meta-analysis was conducted using a 
random effects model, producing standardized mean differences. The studies yielded 
from our search varied considerably with respect to the populations sampled, with some 
studies recruiting exclusively male participants (Kohanpour and Peeri, 2017) or 
exclusively female participants (Damirchi et al., 2018), for example. A random-effects 
model accounts for data that may include studies sampled from varying populations, for 
which any potential effects of the intervention may differ. To account for these 
differences in sampling and the assumption that all studies are not functionally 
equivalent, we used a random-effects model. To assess heterogeneity (the extent to which 





0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Other bias
Selective reporting (reporting bias)
Incomplete outcome data (attrition bias) - Post-Intervention
Blinding of outcome assessment (detection bias)
Blinding of participants and personnel (performance bias)
Allocation concealment (selection bias)
Random sequence generation (selection bias)
Figure 2.1 Risk of bias graph. Green = low risk; red = high risk; yellow = unclear; 




























































































































































































































Alghadir et al., 2016 ? ? ? ? ? ? NA 
Baker et al., 2010a ? ? ? + - ? NA 
Baker et al., 2010b ? ? ? + - ? NA 
Cassilhas et al., 2007 ? ? ? ? + ? NA 
Chupel et al., 2017 ? ? ? ? - ? NA 
Damirchi et al., 2018 ? ? ? ? - ? NA 
Erickson et al., 2011 ? ? ? ? ? ? NA 
Fragala et al., 2014 ? ? ? ? + ? NA 
Kohanpour et al., 2017 ? ? ? ? ? ? NA 
Leckie et al., 2014 ? ? ? ? ? ? NA 
Maass et al., 2016 ? ? ? ? - ? N/A 
Muscari et al., 2009 ? ? ? + + ? N/A 
Rehfeld et al., 2018 ? ? ? ? + + NA 
Ruiz et al., 2015 + ? ? + + + NA 
Tarazona-Santabalbina et al., 2016 + + ? + + + NA 
Tsai et al., 2015 + ? ? + + ? NA 
Vaughan et al., 2014 + + - + + + NA 
Figure 2.22Risk of bias summary. Green (+) = low risk; red (-) = high risk; yellow (?) 




2.2  Results 
2.2.1 Search Results and Bias Assessment 
Figure 2.1 summarizes all steps in the study selection process. A total of 942 articles 
were identified by searching PubMed (n = 215), EMBASE (n = 268), and SCOPUS 
(n = 459). 204 duplicates were removed. The remaining 738 articles were then screened 
via their title and abstract, resulting in 55 articles for full-text screening. Reviewers 
removed 39 articles that did not meet the inclusion criteria, and one article was added via 
the hand search (Tarazona-Santabalbina et al., 2016). In total, 17 articles were found to 
have met the inclusion criteria. 
All included articles were published from 2007 to 2018 (Alghadir et al., 2016; Baker et 
al., 2010a, b; Cassilhas et al., 2007; Chupel et al., 2017; Damirchi et al., 2018; Erickson 
et al., 2011; Fragala et al., 2014; Kohanpour and Peeri, 2017; Leckie et al., 2014; Maass 
et al., 2016; Muscari et al., 2010; Rehfeld et al., 2018; Ruiz et al., 2015; Tarazona-
Santabalbina et al., 2016; Tsai et al., 2015; Vaughan et al., 2014). The inter-rater 
agreement was high (Title and Abstract Kappa = 0.76; Full-Text Kappa = 1.00) during the 
screening process (Supplemental Material 2). 
The majority of items measuring bias were rated “Unclear” for each trial, with the 
exception of two articles (Ruiz et al., 2015; Vaughan et al., 2014). Random sequence 
generation, allocation concealment, blinding of participants and personnel, and selective 
reporting were predominantly ranked “Unclear,” as many studies did not report these 
methods in detail. Studies frequently reported the blinding of outcome assessments, but 
many authors did not indicate any specific blinding procedures. The item assessing the 
extent to which outcome data reported in the studies was incomplete was more frequently 
ranked as “High” or “Low,” as opposed to “Unclear,”. Because randomized controlled 
trials were pre-registered in national databases which showed an explicit record of the 
initial plan of the study and outcome data, we were able to assess risk of bias in each 




Table 2.3 Characteristics of studies utilizing aerobic exercise interventions. 
Author Country 








Mean Age  
in Years (SD) 
Exercise Type  Duration 





Healthy  100 (35) 
I: 66.8 (3.7) 
C: 67.3 (2.8) 
Aerobic 
Training 
24 weeks,  
3x/ week, 
45-60 mins 
CRP: =  
(decreased in both 
I and C) 
EF:  ↑, LM:  ↑, CA:  ↑,  
Lang:  ↑, P-MF:  ↑  




T2DM 28 (18) 
I: 66 (6.0) 








EF: ↑, CA: ↑,  
LM: =, Lang: = 
Baker et al.,  
2010b USA 
Older Adult,  
MCI 33 (17) 
I: F: 65.3 (9.4) 
M: 70.9 (6.7) 
C: F: 74.6 (11.1) 






BDNF: M/F: = 
IGF-1: F: =, M: ↑  
EF: F: ↑, M: = 
CA: F: ↑, M: = 
Lang: F: ↑, M: = 
LM: M/F: = 
Erickson  
et al., 2011 USA 
Older Adults,  
Healthy 120 (80) 
I: 67.6 (5.81) 





40 mins BDNF: = LM: =  
Kohanpour  
et al., 2017 Iran 
Older Adults, 
MCI, Males 61 (0) 
67.85 (3.89) 





26 mins BDNF: ↑ GC: ↑ 
Leckie et  
al., 2014 USA 
Older Adults,  
Healthy 92 (59)  
I: 67.23 (5.39) 





40 mins BDNF: = EF: = 
Maass et  
al., 2016 Germany 
Older Adults,  
Healthy 40 (22) 
I: 68.8 (4.5) 










VEGF: = LM: = 
Muscari et  
al., 2009 Italy 
Older Adults, 
Healthy 120 (58) 
I: 68.8 (2.5) 





60 mins CRP: ↓ GC: ↑ 
Rehfeld et  
al., 2018 Germany 
Older Adults,  
Healthy 38 (20) 
I1: 68.16 (4.31) 





90 mins BDNF: I1: ↑ 
EF: =, CA: ↑,  
LM: ↑, Lang: = 
Note: Articles are listed in alphabetical order. Studies with multiple interventions are numbered i.e. I1, I2, etc. Age (years) is mean ± standard deviation. I = 
intervention; C = control; Where males and females are measured separately, M = male, F = female; BDNF = brain derived neurotrophic factor; IGF-1 = insulin-
like growth factor; VEGF = vascular endothelial growth factor; CRP: c-reactive protein; IL-6: interleukin 6; CA: complex attention; EF = executive function; LM 
= learning and memory; Lang = language; P-MF = perceptual-motor function; GC = general cognition; DNR = did not report; ↑ = significantly increased; ↓ = 




Table 2.4 Characteristics of studies utilizing resistance training interventions. 
Author Country 






Sample Size  
(Female) 
Mean Age  
in Years (SD) 
Exercise Type  Duration 
Cassilhas  
et al. 2007 Brazil 
Older Adult, 
Healthy, Males 62 (0) 
I1: 68.04 (0.67) 
I2: 69.01 (1.10) 
C: 67.04 (0.54) 
Resistance:  
I1: (80% 1rm) 




IGF-1: I1: ↑ 
I2: ↑ 
LM: I1:  ↑  
        I2: ↑ 
CA: I1:↑  
        I2: ↑ 
Chupel et 
 al., 2017 Portugal 
Institutionalized, 
Older Adult,  
MCI, Females 33 (33) 
I: 83.50 (5.13) 
C: 82.12 (6.41) Resistance 
28 weeks, 
2-3x/week, 
mins DNR CRP: = GC: ↑ 
Fragala et  
al., 2014 USA 
Older Adults, 






mins DNR BDNF: = P-MF: ↑ 
Tsai et al., 
2015 Taiwan 
Older Adults,  
Healthy, Males 48 (0) 
I: 70.79 (3.39) 
C: 72.00 (4.14) Resistance 
52 weeks, 
3x/ week, 
60 mins IGF-1: ↑ CA: ↑  
Note: Articles are listed in alphabetical order. Studies with multiple interventions are numbered i.e. I1, I2, etc. Age (years) is mean ± standard deviation. I = 
intervention; C = control; Where males and females are measured separately, M = male, F = female; BDNF = brain derived neurotrophic factor; IGF-1 = insulin-
like growth factor; VEGF = vascular endothelial growth factor; CRP: c-reactive protein; IL-6: interleukin 6; CA: complex attention; EF = executive function; LM 
= learning and memory; Lang = language; P-MF = perceptual-motor function; GC = general cognition; DNR = did not report; ↑ = significantly increased; ↓ = 

















Table 2.5 Characteristics of studies utilizing multimodal exercise interventions. 
Author Country 







Sample Size  
(Female) 
Mean Age  
in Years (SD) 
Exercise Type  Duration 
Damirchi et  
al., 2018 Iran 
Older Adults, MCI,  
Females 20 (20) 
I: 68.81 (3.68) 









Ruiz et  
al., 2015 Spain 
Institutionalized, 
Older Adults, 
Non-demented 40 (32) 
I: 92.1 (2.3) 
C: 92.3 (2.3) Aerobic, Resistance 
8 weeks, 
3x/ week, 
45 mins BDNF: = GC: = 
Tarazona-
Santabalbina  
et al. 2016 Spain 
Older Adults,  
Frail 100 (54) 
I: 79.7 (3.6) 







65 mins BDNF: = GC: = 
Vaughan et  
al., 2014 Australia 
Older Adults,  
Healthy, Females 48 (48) 
I: 69.0 (3.1) 











Rehfeld et  
al., 2018 Germany 
Older Adults,  
Healthy 38 (20) 
 











Note: Articles are listed in alphabetical order. Studies with multiple interventions are numbered i.e. I1, I2, etc. Age (years) is mean ± standard deviation. I = 
intervention; C = control; Where males and females are measured separately, M = male, F = female; BDNF = brain derived neurotrophic factor; IGF-1 = insulin-
like growth factor; VEGF = vascular endothelial growth factor; CRP: c-reactive protein; IL-6: interleukin 6; CA: complex attention; EF = executive function; LM 
= learning and memory; Lang = language; P-MF = perceptual-motor function; GC = general cognition; DNR = did not report; ↑ = significantly increased; ↓ = 













Table 2.6 Exercise Parameters. 
 FITT-VP 








Alghadir et al., 
2016 
I: 3x/week for 24-
weeks 
I: 60-70% of target HR max (Karvonen 
method) 
I: 45-60 
I: Aerobic exercise 
C: Unclear 
I: 135-180 I: Not reported 
Baker et al., 
2010a 
I: 4x/week for 6-
months 
I: Exercise duration and intensity were 
gradually increased over the first 6 weeks 
until exercising at 75% to 85% of HRR, 
and then remained at that intensity 
I: 45-60 
I: Aerobic exercise 
C: Stretching and balance 
I: 180-240 I: See Intensity 
Baker et al., 
2010b 
I: 4x/week for 6-
months 
I: Exercise duration and intensity were 
gradually increased over the first 6 weeks 
until exercising at 75% to 85% of HRR, 
and then remained at that intensity 
I: 45-60 
I: Aerobic exercise 
C: Stretching and balance 
I: 180-240 I: See Intensity 
Erickson et al., 
2011 
I: 3x/week for 1-year 
I: 50-60 % week 1-7; 60-75% of target HR 
max (Karvonen method) for remainder 
I: 10-40 
I: Aerobic exercise 
C: Stretching and toning 
I: 30-120 
I: 5-min increments from week 
1-7 and then remained at 40-
minutes for remainder 
Kohanpour et al., 
2017 
I: 3x/week for 12-
weeks 
I: 75%- 85% of HRR max I: 8-26 
I: Aerobic exercise 
C: Unclear 
I: 24-78 
I: 5-min increments from week 
1-7 and then remained at 40-
minutes for remainder 
Leckie et al., 
2014 
I: 3x/week for 1-year 
I: 50-60 % week 1-7; 60-75% of target HR 
max (Karvonen method) for remainder 
I: 10-40 
I: Aerobic exercise 
C: Stretching and toning 
I: 30-120 
I: 5-min increments from week 
1-7 and then 40-minutes for 
remainder of program 
Maass et al., 2016 
I: 3x/week for 3-
months 
I: Target HR (Karvonen et al.), starting at 
65%  
I: 5-30 
I: Aerobic exercise  
C: Muscle relaxation and 
stretching 
I: 15-90 
I: Increasing by 5% in steps for 
4 weeks 
Muscari et al., 
2009 
I: 3x/week for 12-
months 
I: Individually programmed in an 
incremental manner, up to 70% of max HR 
I: 60 
I: Aerobic exercise 
C: Educational material  
I: 180 I: See Intensity 
Rehfeld et al., 
2018 
I1 & I2: 2x/week for 6-
months 
I1 & I2: Measured HR frequency  
I1 & I2: 
90 
I1: Dance 
I2: "Sport" (Aerobic, 
Resistance, and Flexibility 
Training) 
I: 180 
I1: Continuous learning of new 
movement patterns and 
choreographies, 
I2: Performed same exercises 
repeatedly 
Chupel et al., 
2017 
I: 2x/week for 8-weeks 
+3x/week for 12-weeks 
+2x/week for 8-weeks 
I: 6-8 on the OMNI-PES I: 45 
I: Resistance exercise 
C: Did not follow any type 
of exercise program 
I: 90-135 
I: Weeks 1-14 = yellow band; 




Cassilhas et al. 
2007 
I1 & I2: 3x/week for 
24-weeks 
I1: 50 of 1-RM 
I2: 80% of 1-RM 
I: 60 
I1 & I2: Resistance 
exercise  
C: Warm-up and stretching 
I: 180 
I1 & I2: 1-RM testing repeated 
at week 10, 15, 18, and 21 
Fragala et al., 
2014 
I: 2x/week for 6-weeks I: 5-6 on the OMNI-PES 
I: Not 
reported 
I: Resistance exercise 
C: No intervention 
I: Unclear See Intensity 
Tsai et al. 2015 
I: 3x/week for 12-
months 
I: 75–80% 1- RM I: 60 
I: Resistance exercise 
C: Did not receive a 
specific intervention or 
group activity 
I: 180 
I: As each individual’s muscle 
strength increased, their 
prescribed training load was also 
raised to ensure they performed 
the training at taregt 1-RM 
Damirchi et al., 
2018 
I: 3/week for 8-weeks 
I: Aerobic = 55 - 75 % of HRR 
(Karvonen)  
Resistance = RPE within 13 to 15 range 
I: 41-55 
I: Multi-domain (aerobic 
and resistance exercise) 
C: no intervention 
I: 123-165 
I: Aerobic = incrementally 
reached max HRR by eighth 
week 
Resistance = not reported 
Ruiz et al., 2015 I: 3x/week for 8-weeks 
I: Aerobic = 10-12 on Borg’s conventional 
6–20 point scale of RPE (confirmed via 
talk test) 
Resistance training = 30-70% of estimated 
1-RM  
I: 40-45 
I: Multi-domain (aerobic, 
resistance, and stretching 
exercises) 
C: Gentle stretching 
I: 120-135 
I: Aerobic = lasted from 5min at 
the start of the program to 10–
15min at the end 
Resistance = weekly load 




I: 5x/week for 24-
weeks 
I: Aerobic training = 40-65% of maximum 
HR, increasing progressively to 65% 
Strength training = 25% of 1-RM for 
months 1-2, 50% for months 3-4, and 75% 
for months 5-6 
I: 65 
I: Multi-domain (aerobic, 
strength, coordination, 
balance, and flexibility 
exercises) 
C: No training 
I: 325 
I: Aerobic = increased 
progressively 
Resistance = See intensity - 
repetitions and sets were also 
manipulated 
Vaughan et al., 
2014 
I: 2x/week for 16-
weeks 
I: Aerobic = 3-4/10 RPE 
Resistance = 2 sets of 6-8 reps 
I: 60 
I: Multi-domain (aerobic, 
strength, and motor fitness) 
C: Maintained usual 
activities 
I: 120 
I: Aerobic = Increasing number 
of simultaneous limb 
movements 
Resistance = Commence with 
no weight, progress to light 
weights (1kg) 
 
Note. Details of exercise interventions according to FITT-VP (Frequency, Intensity, Time, Type, Volume, and Progression) parameters. Note that some exercise interventions did 
not clarify an element of the parameters. Volume is calculated as sessions per week x minutes per session and therefore, a range is required for some studies, which represents the 
lowest and highest number of minutes required. Volume does not account for rest periods in interventions that included resistance exercise. Additionally, we did not include 
information on modalities (e.g., machine, free-weight, bands, etc.), or repetition, rest, and set schemes for resistance exercise. HR = heart rate; HRR = heart rate reserve; OMNI-PES 



























      to study 
• 211 articles: Duplicate articles 
• 8 articles: exercise modality 
unclear/nonexistent/acute 
• 9 articles: incorrect cohort 
• 7 articles: lacking/subjective measure of cognition 
• 1 article: insufficient blood data measured/reported 
Database Search (n=942) 
PubMed = 215 
EMBASE = 268 
SCOPUS = 459 
Full-text articles assessed for 
eligibility 
n=55 































Articles excluded (n=887) 
Reason:  
• 676 articles: Title and 
abstract irrelevant 
       to study 
• 211 articles: Duplicate 
articles 
Articles added from references 
(n=1) 
Full-text articles excluded (n=39) 
Reason: 
• 14 articles:  not RCT 
• 8 articles: exercise modality 
unclear/nonexistent/acute 
• 9 articles: incorrect cohort 
• 7 articles: lacking/subjective 
measure of cognition 
• 1 article: insufficient blood 
data measured/reported 
Articles included in systematic 
review 
n= 17 




2.2.2  Study Populations 
The sample sizes of included studies ranged from 20 to 120 (n = 1008), 555 of whom 
were female (55 %). Three trials recruited exclusively male participants (Cassilhas et al., 
2007; Kohanpour and Peeri, 2017; Tsai et al., 2015), while two studies exclusively 
recruited females (Chupel et al., 2017; Damirchi et al., 2018). One trial did not report the 
sex of their 25 participants (Fragala et al., 2014). Mean (sd) ages of the intervention 
groups ranged from 66.0 (6.0) to 92.1 (2.3). Study populations were mostly drawn from 
the general public (Alghadir et al., 2016; Baker et al., 2010a, b; Cassilhas et al., 
2007; Damirchi et al., 2018; Erickson et al., 2011; Fragala et al., 2014; Kohanpour and 
Peeri, 2017; Leckie et al., 2014; Maass et al., 2016; Muscari et al., 2010; Rehfeld et al., 
2018; Tarazona-Santabalbina et al., 2016; Tsai et al., 2015; Vaughan et al., 2014), with 
the exception of two trials of institutionalized older adults (Chupel et al., 2017; Ruiz et 
al., 2015). The predominant cohorts were cognitively healthy (n = 13) (Alghadir et al., 
2016; Baker et al., 2010a; Cassilhas et al., 2007; Chupel et al., 2017; Erickson et al., 
2011; Fragala et al., 2014; Leckie et al., 2014; Maass et al., 2016; Muscari et al., 
2010; Rehfeld et al., 2018; Tarazona-Santabalbina et al., 2016; Tsai et al., 2015; Vaughan 
et al., 2014); followed by MCI (n = 3) (Baker et al., 2010a; Damirchi et al., 
2018; Kohanpour and Peeri, 2017). One study labelled their criteria as “not severely 
demented”, but reported mean cognitive scores in the range of MCI at baseline (Ruiz et 
al., 2015). 
 
2.2.3  Exercise Protocols 
The included studies used the following modalities: aerobic training (AT) (Alghadir et 
al., 2016; Baker et al., 2010a, b; Erickson et al., 2011; Kohanpour and Peeri, 
2017; Leckie et al., 2014; Maass et al., 2016; Muscari et al., 2010; Rehfeld et al., 2018); 
resistance training (RT) (Cassilhas et al., 2007; Chupel et al., 2017; Fragala et al., 
2014; Tsai et al., 2015); and multimodal (MMT), which includes AT and RT (Damirchi 
et al., 2018; Ruiz et al., 2015), with stretching (Rehfeld et al., 2018), proprioception 




2014). The trial by Rehfeld et al. (2018) employed two distinct exercise interventions 
(dance and multimodal), both of which were included in this review. Two trials utilized 
multi-domain interventions including the use of lavender essence (Kohanpour and Peeri, 
2017) and cognitive training (Damirchi et al., 2018). However, both trials included 
exercise-only groups, so the multi-domain interventions were not incorporated in the data 
extraction. 
2.2.4  Aerobic Training (AT) 
Nine trials included AT interventions, with sample sizes ranging from 28 to 120 
participants, reaching a total of 632 participants, 49 % of whom were female. All trials 
recruited participants from the general public. One trial recruited exclusively male 
participants (Kohanpour and Peeri, 2017). Two trials recruited participants with MCI 
(Baker et al., 2010a; Kohanpour and Peeri, 2017), while the remaining seven trials 
recruited cognitively intact older adults. 
Interventions ranged from 12 to 52 weeks, 2–4 sessions per week, and from 26−90 min. 
The AT was performed using ergometers (e.g. treadmill, stationary bike, etc.) or walking, 
running, and dancing. The intensity of AT was controlled by heart rate reserve and 
ratings of perceived exertion (Table 2.3). 
Of the nine studies that investigated AT, seven measured growth factors (Baker et al., 
2010a, b; Erickson et al., 2011; Kohanpour and Peeri, 2017; Leckie et al., 2014; Maass et 
al., 2016; Rehfeld et al., 2018) and two measured inflammatory markers (Alghadir et al., 
2016; Muscari et al., 2010). Two of the seven studies measuring BDNF found a 
significant increase in BDNF concentration (Kohanpour and Peeri, 2017; Rehfeld et al., 
2018), and five studies did not find any significant changes (Baker et al., 
2010a, b; Erickson et al., 2011; Leckie et al., 2014; Maass et al., 2016). One study 
measured VEGF and did not find significant changes (Maass et al., 2016). Only one of 
the three studies measuring IGF-1 showed a significant increase in concentration; 
however, this was only in the males (Baker et al., 2010b). Of the studies exhibiting a 




measured BDNF showed improvements in cognitive performance (Kohanpour and Peeri, 
2017). However, no formal analysis examined the relationship between the changes in 
BDNF concentration and cognitive outcomes. The majority of AT trials elicited 
improvements in at least one cognitive domain (n = 6) (Alghadir et al., 2016; Baker et al., 
2010a, b; Kohanpour and Peeri, 2017; Muscari et al., 2010; Rehfeld et al., 2018). Overall, 
there was no consistent pattern in the review of these articles that linked the duration, 
frequency, or time spent on the AT to cognitive and growth factor changes. 
Both of the studies measuring the effect of AT on inflammatory markers examined CRP. 
Only one study showed a significant decrease in CRP concentration post-intervention 
(Muscari et al., 2010). Both studies measuring CRP found cognitive improvements 
(Alghadir et al., 2016; Muscari et al., 2010). 
2.2.5  Resistance Training (RT) 
Four trials used RT interventions, and they included a total of 168 participants (ranging 
from 25−62 participants), 19 % of whom were female. Recruitment was from the general 
public (Cassilhas et al., 2007; Fragala et al., 2014; Tsai et al., 2015) and an institution 
(Chupel et al., 2017). Two trials recruited exclusively male participants (Cassilhas et al., 
2007; Tsai et al., 2015) and one recruited female participants (Chupel et al., 2017). Two 
trials recruited participants with MCI (Chupel et al., 2017; Tsai et al., 2015) and two 
recruited cognitively intact older adults (Cassilhas et al., 2007; Fragala et al., 2014). 
The RT interventions ranged from 6 to 52 weeks, 2−3 times per week, and lasted 60 min 
in the two studies that reported the session durations. The RT interventions utilized 
resistance bands and machines. Each trial used a range of 1–3 sets per exercise and 8–15 
reps per set, depending on the intervention phase. The intensity of exercises was 
monitored using the 1-repetition maximum test and ratings of perceived exertion (Table 
2.4). 
Three out of four RT interventions measured neurotrophic factor concentrations 
(Cassilhas et al., 2007; Fragala et al., 2014; Tsai et al., 2015), while one measured 




factors, two measured IGF-1 (Cassilhas et al., 2007; Tsai et al., 2015), and one measured 
BDNF (Fragala et al., 2014). Both of the studies measuring IGF-1 demonstrated a 
significant increase in IGF-1 concentration, as well as a significant increase in cognitive 
scores (Cassilhas et al., 2007; Tsai et al., 2015). The interventions that measured BDNF 
(n = 1) and the inflammatory marker CRP (n = 1) did not elicit significant changes 
(Chupel et al., 2017; Fragala et al., 2014) (Table 2.4). 
2.2.6  Multimodal Training (MMT) 
Five trials used MMT interventions (Damirchi et al., 2018; Rehfeld et al., 2018; Ruiz et 
al., 2015; Tarazona-Santabalbina et al., 2016; Vaughan et al., 2014) and ranged from 20 
to 100 participants (n = 226), 72 % of whom were female. Recruitment was from the 
general public (Damirchi et al., 2018; Rehfeld et al., 2018; Tarazona-Santabalbina et al., 
2016; Vaughan et al., 2014) and an institution (Ruiz et al., 2015). Two trials recruited 
exclusively male participants (Cassilhas et al., 2007; Tsai et al., 2015), and one trial 
recruited only female participants (Chupel et al., 2017). One trial recruited participants 
with MCI (Damirchi et al., 2018), as opposed to cognitively intact older adults (n = 4). 
The MMT interventions ranged from 8 to 24 weeks, were performed 3–5 times per week 
and lasted 45−90 min. The RT portions of the MMT interventions utilized low-impact, 
multi-use devices, such as chairs, balls, resistance bands, light dumbbells, and resistance 
machines. The AT portions of each study used ergometers, walking, or stairs for 
10−40 min. Intensity was measured by using heart rate reserve and ratings of perceived 
exertion. Three of the five studies also used other exercise modalities such as stretching 
(Rehfeld et al., 2018), stretching and proprioception (Tarazona-Santabalbina et al., 2016), 
or stretching and motor fitness (Vaughan et al., 2014) (Table 2.5). 
Every included MMT intervention measured BDNF concentration (n = 4), but only one 
demonstrated a significant increase in concentrations post-intervention (Vaughan et al., 
2014). However, two MMT interventions showed improvements to cognitive 




2.2.7  Sex Differences 
All of the three studies that only included males resulted in a significant increase in 
neurotrophic factor concentrations and also showed significant increases in cognitive 
scores (Cassilhas et al., 2007; Kohanpour and Peeri, 2017; Tsai et al., 2015). The one 
study measuring sex differences in the same sample showed significant increases in 
neurotrophic factor concentrations in males, however no significant improvements were 
seen in the cognitive scores. Conversely, the females in this sample exhibited 
significantly improved cognitive performance, but did not show changes in neurotrophic 
concentrations (Baker et al., 2010b). Two of the three studies that exclusively recruited 
females did not show any significant changes to blood marker concentrations (Chupel et 
al., 2017; Damirchi et al., 2018). Significant improvements in cognitive performance 
were elicited for two thirds of the female-only trials (Chupel et al., 2017; Vaughan et al., 
2014). 
2.2.8  Cognitive Performance after Exercise 
In total, 11 out of 18 interventions increased performance in at least one cognitive 
domain. Specifically, complex attention improved in seven and eight of nine 
interventions in males and females, respectively (Alghadir et al., 2016; Baker et al., 
2010a, b; Cassilhas et al., 2007; Rehfeld et al., 2018; Tsai et al., 2015; Vaughan et al., 
2014); executive function improved in three and four of six interventions for males and 
females, respectively; learning and memory improved in four and four of nine 
interventions for males and females, respectively; language improved in two and three 
interventions for males and females, respectively (Alghadir et al., 2016; Baker et al., 
2010b; Vaughan et al., 2014); perceptual-motor function improved in two and two of two 
interventions for males and females, respectively (Alghadir et al., 2016; Fragala et al., 
2014); and global cognition improved in three and three of five interventions for males 
and females, respectively (Chupel et al., 2017; Kohanpour and Peeri, 2017; Muscari et 




Seven trials performed correlation analyses of changes in blood marker concentrations 
and cognitive performance (Alghadir et al., 2016; Damirchi et al., 2018; Erickson et al., 
2011; Fragala et al., 2014; Maass et al., 2016; Ruiz et al., 2015; Tsai et al., 2015). CRP 
had a strong negative correlation with every cognitive domain in one trial (Alghadir et al., 
2016). BDNF did not have a significant correlation with cognitive performance 
(Damirchi et al., 2018; Erickson et al., 2011; Fragala et al., 2014; Ruiz et al., 2015). IGF-
1 was had a moderate positive correlation with learning and memory (Maass et al., 2016) 
and complex attention (Tsai et al., 2015) performance. One trial found that BDNF was a 
mediator of the exercise-executive function relationship as a function of age (Leckie et 
al., 2014). 
2.2.9  Meta-Analyses Results  
Studies examining changes following aerobic training in CRP, IL-6, and VEGF did not 
meet the minimum criteria of at least three independent studies. However, eight 
independent studies examined BNDF concentrations in individuals assigned to control or 
active experimental conditions, and were therefore included in the meta-analysis 
(Damirchi et al., 2018; Erickson, 2010; Fragala et al., 2014; Kohanpour and Peeri, 
2017; Leckie et al., 2014; Maass et al., 2016; Tarazona-Santabalbina et al., 
2016; Vaughan et al., 2014). 
2.2.10  Weighted Results 
As evidenced in Figure 2.4, of the eight studies, only one (Kohanpour and Peeri, 2017) 
yields results that favour the hypothesis that the experimental group has higher BDNF 
concentrations post intervention (relative to the control group). This is evidenced by the 
fact that the 95 % confidence interval wings extend entirely within the right hand side 
of Fig. 4. It is critical to note that while the results of this study are uniquely 
heterogeneous relative to the other seven studies—the sample size of Kohanpour and 
Peeri (2017) is very small (N = 10 in each group)—thus it had a low overall weight in the 




Santabalbina et al., 2016)—and therefore overall weights—demonstrate no particular 















2.2.11  Overall Effect 
Across the eight studies, there is a moderate degree of heterogeneity (I2 = 44 %), thus the 
findings should be interpreted with caution. The overall results are slightly in favour of 
the hypothesis that aerobic exercise yields higher BDNF concentrations, as compared to 
control exercises. But importantly, as depicted in Fig. 4, there is some overlap across the 
center line of no effect. This indicates that the overall effect is not completely indicative 
of increased BDNF post intervention and this is confirmed statistically, as the test of the 
overall effect is not significant, Z = 1.12, p = .26. 
2.3  Discussion 
This systematic review and meta-analysis investigated the effects of physical exercise on 
inflammatory and neurotrophic biomarker concentrations in clinical trials that aimed to 
improve cognition as a primary outcome. We found that exercise interventions, 
independent of the modality, were associated with changes in neurotropic and 
inflammatory blood marker concentrations in 8 of the 18 trials. IGF-1 was the most 
responsive to exercise, independent of modality. Aerobic training primarily increased or 
did not change BDNF concentration while resistance training increased IGF-1 
concentration. MMT interventions elicited changes to BDNF in one of four trials. Males 
demonstrated greater blood marker changes in response to exercise. Finally, 11 of 17 
trials resulted in an improvement in at least one domain of cognition and 5 (46 %) of 
those trials also demonstrated positive changes in biomarker concentrations. IGF-1 
showed moderate positive correlations with LM and CA, while CRP was negatively 
correlated with all cognitive domains in one trial. There were no significant correlations 
between BDNF and cognitive outcomes. 
Since the time of running this search (January 2019), two large scale studies have been 
published (as of December 2020) that show similar trends. Specifically, a study in which 




mindfulness training, or an active control found that the aerobic training group did not 
show significant changes in BDNF following the intervention (Ledreux et al., 2019). 
Similarly, another recently published study with 112 nursing home residents in Spain 
discerned that multimodal training did not significantly change BDNF concentrations in 
the intervention condition (Arrieta et al., 2020). These findings are consistent with the 
findings of our systematic review indicating that BDNF concentrations either 
increase or remain unchanged following aerobic or MMT interventions. 
Lastly, although our systematic review excluded RCTs in which the intervention 
consisted of only one acute, single bout intervention session, a recent study found a 
significant increase in BDNF concentrations following an acute bout of high-intensity 
exercise (Devenney et al., 2019). This, too, is consistent with our findings that AT either 
increases or does not change BDNF concentrations. 
2.3.1  Effects of Exercise Modalities on Blood Markers and 
Cognition 
AT was the most commonly studied intervention strategy (n = 9), followed by MMT 
(n = 5), and RT (n = 4). The AT interventions were associated with positive changes in 
BDNF and improved cognitive performance in six of the nine trials. Two RT 
interventions increased IGF-1 concentrations, but all four RT interventions improved 
cognitive performance. Interestingly, only one of five MMT intervention led to 
significant increases in BDNF concentration and two trials improved cognitive 
performance. 
Consistent with the results of this review, previous research has suggested that AT 
increases BDNF concentrations, while RT primarily functions to increase IGF-1 
concentrations (Cassilhas et al., 2012). As all MMT programs in this review utilize both 
RT and AT, we can expect that a more interactive cascade can be driving the observed 
cognitive improvements. Thus, more comprehensive measurements of neurotrophic and 
inflammatory markers are necessary to delineate the potentially divergent mechanisms 




Recent systematic reviews and meta-analyses measuring the effect of exercise on 
biomarkers in older adults with MCI or dementia reported that exercise significantly 
increased BDNF concentrations and significantly decreased IL-6 and tumor necrosis 
factor-α (TNF-α) concentrations (Stigger et al., 2019). These results may relate to the 
relatively low baseline concentration of neurotrophic factors (Xie et al., 2019) or high 
concentrations of inflammatory cytokines in individuals with MCI or dementia (Öztürk et 
al., 2007), compared to healthy older adults. This may indicate that participants who have 
cognitive impairments have more room to ameliorate concentrations of neurotrophic and 
inflammatory markers after longitudinal exercise, while cognitively intact participants 
may be limited by a ceiling effect. However, data from the studies that recruited 
participants with MCI (n = 4) did not suggest that exercise was more effective at 
increasing or decreasing growth factor and inflammatory cytokine concentrations, 
respectively, for participants with cognitive impairments (Baker et al., 2010b; Fragala et 
al., 2014; Tsai et al., 2015). Previous reviews of exercise effects on neurotrophic and 
inflammatory concentrations were limited by the number of trials and heterogeneity, 
especially when considering the complexity and interactive nature of the variables 
(Stigger et al., 2019). Notably, the Stigger et al. (2019) review did not include studies 
with healthy control participants—but ours did. Additionally, like the Stigger et al. 
(2019) review, we also conducted a meta-analysis on the data extracted. 
Overall, the results of the meta-analysis suggest a minimal trend towards increases in one 
growth marker (BDNF) following aerobic exercise. This finding, however, is not 
statistically significant. Heterogeneity across studies paired with small sample sizes and 
the lack of studies meeting our inclusion criteria that examine biological markers aside 
from BDNF strongly suggest that this field is wanting of more robust research. 
One hypothesis explaining the heterogeneity in biomarker concentrations post 
intervention across studies may be the variability in exercise parameters (see Table 2.6). 
Generally, there was considerable variability across all exercise parameters (frequency, 
intensity, time, type, volume, and progression). For example, total volume of exposure 
across studies ranged from 15−325 min per week; thus, in some studies, volume of 




aerobic activity for older adults (https://csepguidelines.ca/adults-65/) to 240 min per 
week. The variability observed across studies in exercise training exposure does not 
appear to explain the differences across studies in blood marker concentrations post 
intervention. For example, the Kohanpour and Peeri (2017) study showed a robust 
increase in BDNF concentrations following intervention; however, exposure to the 
exercise intervention occurred over only 12 weeks. In contrast, Erickson et al. 
(2011) and Leckie et al. (2014) conducted their exercise intervention sessions over an 
entire year. But despite this prolonged exposure, increases in BDNF concentrations post 
intervention were smaller relative to those observed in other studies (i.e., Kohanpour and 
Peeri, 2017). Taken together, what these data indicate is that differences across studies in 
intervention exposure (exercise frequency) do not appear to shed light on the variability 
observed across studies in biomarker changes post intervention. 
2.3.2  Discussion of Sex Differences 
There were notable sex differences in changes to biomarker concentrations in trials that 
exclusively recruited one sex, as well as the single trial that analyzed sex-differences in 
their sample. In particular, every male-only cohort (n = 3) exhibited increases in 
neurotrophic factor or decreases in inflammatory markers that accompanied significant 
improvements in cognition (Cassilhas et al., 2007; Kohanpour and Peeri, 2017; Tsai et 
al., 2015), but there was no correlation between changes in blood marker and cognitive 
function when analyzed (Tsai et al., 2015). Also, the single trial that measured sex 
differences within their sample found significant improvements to neurotrophic factor 
concentrations in the male, but not the female participants (Baker et al., 2010b). 
Interestingly, none of the female-only cohorts (n = 3) showed changes to blood marker 
concentrations (Chupel et al., 2017; Damirchi et al., 2018; Vaughan et al., 2014). 
The sex-specific biomarker responses might be related to the different exercise modalities 
performed. In particular, two of three female-only cohorts participated in MMT; the only 
modality that did not elicit any changes to blood marker concentrations. Also, no female 
samples exclusively participated in AT. Alternatively, two of three male-only cohorts 




changes to blood marker concentrations and cognitive scores. Interestingly, trials utilizing 
RT were mostly composed of male participants, suggesting that sex might moderate the 
positive neurotrophic outcomes of RT. Thus, the sex differences might be confounded by 
the lack of equal representation of sexes across exercise modalities, or potential sex-
related moderation. Alternatively, there are sex-specific differences within the aging 
process (Barha and Liu-Ambrose, 2018; Gordon et al., 2017), which may be related to the 
sex-specific responses to intervention strategies. This has been addressed by recent 
studies investigating how pre-frail older females respond to free-weight resistance 
training interventions to reduce frailty and improve functional capabilities with promising 
results (Bray et al., 2019a, 2019b). Therefore, increased attention to the sex-specific 
responses to exercise is imperative to improve understanding of this complex 
relationship. 
There is a growing body of literature examining sex-specific responses to exercise 
interventions implemented in older adults at risk for dementia (Barha and Liu-Ambrose, 
2018). For example, results from a recent systematic review and meta-analysis indicate 
that exercise intervention studies in which samples are predominantly female show more 
robust benefits on executive function than those with fewer female participants (Barha et 
al., 2017). These data suggest that the cognitive domains involved in executive 
functioning in women may be more sensitive to the neurological cascade resultant of 
exercise interventions. Additionally, there is evidence suggesting that there may be an 
interaction between the type of exercise intervention and sex on cognitive outcomes. 
Aerobic exercise, for example, appears to be more effective in producing cognitive 
benefits to women than to men (Colcombe and Kramer, 2003). Taken together, the 
literature suggests that sex is a critical factor to consider in studies examining neutrally 
mediated cognitive outcomes of exercise interventions in aging populations. 
2.3.3  Cognitive Performance Outcomes 
In total, 11 out of 18 interventions augmented at least one domain of cognition. More 
specifically, exercise preferentially improved complex attention in seven and eight out of 




function in two of two interventions. These findings strengthen the relationship between 
exercise and cognition, especially in perceptual-motor function, which was the least 
measured cognitive domain in this review. Other domains showed only moderate 
modulation by exercise. Out of the exercise modalities, RT interventions were the most 
effective in augmenting cognitive performance. Further, RT elicited cognitive benefits in 
complex attention, learning and memory, perceptual-motor function, and global 
cognition. Recent research investigating the effect of RT on cognition in older adults also 
demonstrates this relationship. In particular, a systematic review by Li et al. (2018) 
examined the cognitive effects of RT on older adults. Similar to our review, their results 
indicated that longitudinal RT interventions significantly improved executive function 
and global cognition performance. 
From the seven trials that analyzed correlations between the changes in blood marker 
concentrations and cognitive outcomes, IGF-1 seems to have the strongest correlation 
with cognitive performance, showing moderate positive correlations to complex attention 
(Tsai et al., 2015) and learning and memory (Maass et al., 2016). The relationship 
between IGF-1 and cognition is inconsistent. For example, some work has shown that 
IGF-1 is positively correlated with cognition (Okereke et al., 2006) but others suggested 
that it is negatively correlated with cognition (Stein et al., 2018). Further, it has been 
suggested that moderate, as opposed to a high or low, concentrations of systemic IGF-1 is 
correlated with positive cognitive outcomes (Tumati et al., 2016). Thus, further research 
is needed to evaluate the correlation between IGF-1 and cognitive outcomes after 
exercise. 
Surprisingly, in the four trials that performed correlation analyses, no correlations were 
found between the changes in BDNF and cognitive outcomes. However, consistent with 
previous literature (Vaynman et al., 2004), BDNF was shown to be a mediator of the 
exercise-cognition relationship in one trial (Leckie et al., 2014). To establish more a 
concrete understanding of how growth factors correlate with cognition, more 
comprehensive neuropsychological assessments, growth factor measurements, and 




2.3.4  Future Studies 
This systematic review exposed gaps in the literature. Future research should focus on the 
effect of exercise on multiple neurotrophic and inflammatory markers simultaneously, 
while measuring cognitive performance. An ongoing RCT is examining the effect of 
MMT on BDNF, IGF-1, VEGF, IL-6, CRP and cognitive performance in older adults 
consisting of 200 participants with MCI and may help to decipher the role of these 
neurotrophic and inflammatory markers (Montero-Odasso et al., 2018). Further, research 
should be developed to specific exercise modalities. In addition, the role of sex-related 
factors, such as hormone concentrations and their interactions with neurotrophic and 
inflammatory blood markers, is a potential avenue for further research in this topic. 
Additional reasons for the contrasting findings may be related to the diversity of 
participants in each study. That is, future studies examining varying ethnic backgrounds 
or comorbidities in the populations under study may offer fruitful insights in explaining 
the mixed findings. However, in the present study, the majority of selected studies were 
similar with respect to demographic characteristics such as ethnic background and 
comorbidities. Finally, difference across studies can also be related to the target 
population and when the intervention was provided across the spectrum of the decline. 
Future research focusing on the timing in which interventions are implemented in 
individuals at risk for developing dementia may provide interesting findings. 
2.3.5  Limitations 
Our review has limitations. Firstly, it is possible that our search strategy missed relevant 
material in our selected databases. Additionally, the included studies were heterogeneous 
in terms of exercise modalities and parameters, preferred blood markers, sample sizes, 
cognitive domains measured, and analyses employed. Also, given the limitations of the 
published studies, we reported results as “increase” or “decrease,” which limited the 
examination of the relative effect size of each intervention. Further, only extracting 
results of significance from the trials means that large samples sizes are required, but not 




our review was limited by a lack of available literature that measured both the changes to 
concentrations of blood markers of interest and cognitive performance. 
Regarding our meta-analyses, the eight included studies were limited by small sample 
sizes, with sample sizes ranging from N = 10 per condition to N = 60 per condition, with 
an average sample size of 29 individuals per arm across studies. In addition, studies were 
highly heterogeneous, requiring a high degree of caution in interpreting the results. The 
absence of trials that included the mean change values for inflammatory blood markers 
limited our ability to perform any additional meta-analyses. And finally, trials 
preferentially measured single blood markers (typically BDNF or IGF-1) in the majority 
of cognitive trials and lacked measurements of inflammatory markers. 
2.4  Conclusion 
Exercise has an effect on the serum concentrations of neurotrophic and inflammatory 
marker in cognitive trials. Specifically, AT primarily increased or did not change the 
concentrations of BDNF, while RT increased or did not change the concentrations of 
IGF-1. A small number of trials demonstrated changes in biomarkers may be sex specific, 
as males exhibited greater increases in neurotrophic biomarker concentrations after 
exercise interventions than females. This systematic review was limited by heterogeneity 
of exercise modalities and parameters, as well as the variability in the measurements of 
blood markers and cognition. Despite the limitations, this is the first review to examine 
and compare the effect of the type of exercise on neurotrophic and inflammatory markers 
on cognition in older adults. Based on the gaps detected, we suggest that further research 
on the effect of exercise on cognition should simultaneously measures neurotrophic and 
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